
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis
Anli Jin, Chunyan Zhang, Wenjing Zheng, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 25
Anli Jin, Chunyan Zhang, Wenjing Zheng, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 25
Showing 25 citing articles:
CD155 and its receptors in cancer immune escape and immunotherapy
Ruijia Zhou, Shiyin Chen, Qiwen Wu, et al.
Cancer Letters (2023) Vol. 573, pp. 216381-216381
Closed Access | Times Cited: 16
Ruijia Zhou, Shiyin Chen, Qiwen Wu, et al.
Cancer Letters (2023) Vol. 573, pp. 216381-216381
Closed Access | Times Cited: 16
Unveiling spatial complexity in solid tumor immune microenvironments through multiplexed imaging
Sophia Scheuermann, Beate Kristmann, F. Engelmann, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Sophia Scheuermann, Beate Kristmann, F. Engelmann, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Modulation of the p38 MAPK Pathway by Anisomycin Promotes Ferroptosis of Hepatocellular Carcinoma through Phosphorylation of H3S10
Wei Chen, Wenjing Yang, Chunyan Zhang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 22
Wei Chen, Wenjing Yang, Chunyan Zhang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 22
CD155 in tumor progression and targeted therapy
Meixiao Zhan, Zhiren Zhang, Xiaoguang Zhao, et al.
Cancer Letters (2022) Vol. 545, pp. 215830-215830
Closed Access | Times Cited: 19
Meixiao Zhan, Zhiren Zhang, Xiaoguang Zhao, et al.
Cancer Letters (2022) Vol. 545, pp. 215830-215830
Closed Access | Times Cited: 19
A multidimensional strategy for uncovering comprehensive quality markers of Scutellariae Radix based on UPLC-Q-TOF-MS analysis, artificial neural network, network pharmacology analysis, and molecular simulation
Meiqi Liu, Xiaoran Zhao, Jinli Wen, et al.
Frontiers in Plant Science (2024) Vol. 15
Open Access | Times Cited: 4
Meiqi Liu, Xiaoran Zhao, Jinli Wen, et al.
Frontiers in Plant Science (2024) Vol. 15
Open Access | Times Cited: 4
Anti-colorectal cancer actions of Glycyrrhiza uralensis Fisch. and its underlying mechanism via HPLC integration and network pharmacological approaches
Hong Duan, Zhao‐Jun Wei, Ying Shi, et al.
Phytomedicine (2025) Vol. 138, pp. 156370-156370
Closed Access
Hong Duan, Zhao‐Jun Wei, Ying Shi, et al.
Phytomedicine (2025) Vol. 138, pp. 156370-156370
Closed Access
CD155 promotes the advancement of hepatocellular carcinoma by suppressing the p53-mediated ferroptosis via interacting with CD96
Zhenhui Lu, Jingzhe Yu, Tuoyu Lu, et al.
Journal of Molecular Medicine (2025)
Closed Access
Zhenhui Lu, Jingzhe Yu, Tuoyu Lu, et al.
Journal of Molecular Medicine (2025)
Closed Access
The Proliferative Role of Immune Checkpoints in Tumors: Double Regulation
Xiyang Tang, Zhong-Lin Luo, Yanlu Xiong, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5374-5374
Open Access | Times Cited: 13
Xiyang Tang, Zhong-Lin Luo, Yanlu Xiong, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5374-5374
Open Access | Times Cited: 13
Prognostic and clinicopathological significance of CD155 expression in cancer patients: a meta-analysis
Dan Zhang, Jingting Liu, Mengxia Zheng, et al.
World Journal of Surgical Oncology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 12
Dan Zhang, Jingting Liu, Mengxia Zheng, et al.
World Journal of Surgical Oncology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 12
Celastrol acts as a new histone deacetylase inhibitor to inhibit colorectal cancer cell growth via regulating macrophage polarity
Shuren Wang, Guanghui Hu, Lechuang Chen, et al.
Cell Biology International (2022) Vol. 47, Iss. 2, pp. 492-501
Closed Access | Times Cited: 12
Shuren Wang, Guanghui Hu, Lechuang Chen, et al.
Cell Biology International (2022) Vol. 47, Iss. 2, pp. 492-501
Closed Access | Times Cited: 12
Pan-cancer analysis of immune checkpoint receptors and ligands in various cells in the tumor immune microenvironment
Jiahuan Jiang, Yazhang Xu, Di Chen, et al.
Aging (2024)
Open Access | Times Cited: 2
Jiahuan Jiang, Yazhang Xu, Di Chen, et al.
Aging (2024)
Open Access | Times Cited: 2
DNAM-1 Immunoreceptor Protects Mice from Concanavalin A–Induced Acute Liver Injury by Reducing Neutrophil Infiltration
S. Matsuo, Tsukasa Nabekura, Kenshiro Matsuda, et al.
The Journal of Immunology (2023) Vol. 211, Iss. 6, pp. 954-963
Closed Access | Times Cited: 5
S. Matsuo, Tsukasa Nabekura, Kenshiro Matsuda, et al.
The Journal of Immunology (2023) Vol. 211, Iss. 6, pp. 954-963
Closed Access | Times Cited: 5
Exosomes secreted by metastatic cancer cells promotes epithelial mesenchymal transition in small cell lung carcinoma: The key role of Src/TGF-β1 axis
Yuzhou Shen, Jicheng Tantai
Gene (2023) Vol. 892, pp. 147873-147873
Closed Access | Times Cited: 5
Yuzhou Shen, Jicheng Tantai
Gene (2023) Vol. 892, pp. 147873-147873
Closed Access | Times Cited: 5
PVR—A Prognostic Biomarker Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma
Wenfeng Liu, Bing Quan, Miao Li, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 2953-2953
Open Access | Times Cited: 8
Wenfeng Liu, Bing Quan, Miao Li, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 2953-2953
Open Access | Times Cited: 8
CDK1-SRC Interaction-Dependent Transcriptional Activation of HSP90AB1 Promotes Antitumor Immunity in Hepatocellular Carcinoma
Yijie Zhang, Dehui Yi
Journal of Proteome Research (2023) Vol. 22, Iss. 12, pp. 3714-3729
Closed Access | Times Cited: 4
Yijie Zhang, Dehui Yi
Journal of Proteome Research (2023) Vol. 22, Iss. 12, pp. 3714-3729
Closed Access | Times Cited: 4
Loss of the Novel Mitochondrial Membrane Protein FAM210B Is Associated with Hepatocellular Carcinoma
Yuanqin Zhou, Xianzhu Pan, Yakun Liu, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1232-1232
Open Access | Times Cited: 2
Yuanqin Zhou, Xianzhu Pan, Yakun Liu, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1232-1232
Open Access | Times Cited: 2
CTLA-4 silencing could promote anti-tumor effects in hepatocellular
Amirhossein Mardi, Mahsan Alizadeh, Amir Shahabaddin Abdolalizadeh, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Closed Access
Amirhossein Mardi, Mahsan Alizadeh, Amir Shahabaddin Abdolalizadeh, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Closed Access
Comprehensive analysis of MAPK genes in the prognosis, immune characteristics, and drug treatment of renal clear cell carcinoma using bioinformatic analysis and Mendelian randomization
Xinyi Zheng, Yiqiu Wang, Xiaoyan Qiu
European Journal of Pharmacology (2024) Vol. 980, pp. 176840-176840
Closed Access
Xinyi Zheng, Yiqiu Wang, Xiaoyan Qiu
European Journal of Pharmacology (2024) Vol. 980, pp. 176840-176840
Closed Access
Design of an Artificial Natural Killer Cell Mimicking System to Target Tumour Cells
Vaishali Chugh, K. Vijaya Krishna, Dagmar Quandt, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Vaishali Chugh, K. Vijaya Krishna, Dagmar Quandt, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Diagnostic value of expressions of cancer stem cell markers for adverse outcomes of hepatocellular carcinoma and their associations with prognosis: A Bayesian network meta‑analysis
Zhengrong Ou, Shoushuo Fu, Jian Yi, et al.
Oncology Letters (2024) Vol. 28, Iss. 5
Open Access
Zhengrong Ou, Shoushuo Fu, Jian Yi, et al.
Oncology Letters (2024) Vol. 28, Iss. 5
Open Access
AIBP promotes cell proliferation and migration through the ERK1/2-MAPK signaling pathway in hepatocellular carcinoma
Tianxin Huang, Sijia Ge, Wei Huang, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 8, pp. 4028-4041
Open Access
Tianxin Huang, Sijia Ge, Wei Huang, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 8, pp. 4028-4041
Open Access
Anagrelide and idarubicin combination induces GSDME-mediated pyroptosis as a potential therapy for high-PDE3A acute myeloid leukemia
Chenwei Yang, Yixin Hu, Lijun Gao, et al.
Leukemia (2024)
Closed Access
Chenwei Yang, Yixin Hu, Lijun Gao, et al.
Leukemia (2024)
Closed Access
Poliovirus receptor inhibition in breast cancer cells induces antitumor immunity via T cell activation.
Kyung‐Hee Song, Seung‐Youn Jung, Jeong‐In Park, et al.
PubMed (2023) Vol. 13, Iss. 12, pp. 5966-5980
Closed Access
Kyung‐Hee Song, Seung‐Youn Jung, Jeong‐In Park, et al.
PubMed (2023) Vol. 13, Iss. 12, pp. 5966-5980
Closed Access
AIBP promotes cell proliferation and migration through MAPK/ERK1/2 signaling pathway in hepatocellular carcinoma
Tianxin Huang, Sijia Ge, Wei Huang, et al.
Research Square (Research Square) (2022)
Open Access
Tianxin Huang, Sijia Ge, Wei Huang, et al.
Research Square (Research Square) (2022)
Open Access